O&I Hearing: Examining Biosecurity at the Intersection of AI and Biology

House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations · December 18, 2025

0:00/3:23

3:23:26

0:00

40:00

1:20:00

2:00:00

2:40:00

3:20:00

Chair's opening: risks and promise at AI–biology intersection

0:13 → 4:33(4m 20s)

Chair (speaking as the committee chair) framed the hearing as an inquiry into opportunities for medical breakthroughs and new risks from AI-enabled biotechnology, citing examples such as inexpensive CRISPR kits and LLMs that can walk users through biological processes and may outperform PhD virologists on troubleshooting tasks.

Keywords:

Speakers:

A House Energy and Commerce Subcommittee on Oversight and Investigations hearing examined biosecurity risks where artificial intelligence meets biotechnology. Witnesses urged mandatory gene-synthesis screening, stronger data protections, and expanded detection systems while several members pressed for oversight of HHS leadership.

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Transcript

Unlock the transcript with a paid subscription